COVID-19 Vaccines Protective Against Delta Variant

You’ve likely seen the latest news about the COVID-19 variant quickly becoming the prominent strain in the U.S. It is spreading rapidly and is now responsible for over 51% of new U.S. cases, up from 30% two weeks ago.

The COVID-19 delta variant is found to be about 60% more transmissible than original COVID-19 strain. The latest CDC data shows that due to the COVID-19 delta variant new cases over the last week have increased 9.1% around the country. As of June 30, on average, one COVID-19 related death is still occurring every seven minutes in the U.S. The best measure of protection we have against all variants is the COVID-19 vaccine.

Those fully vaccinated with the Pfizer-BioNTech vaccine have 88% protection against symptomatic COVID-19 and 95% protection against hospitalization and death from the Delta variant. Moderna by initial reports seems equally protective against the delta variant. The Johnson & Johnson vaccine appears 66% protective against the delta variant.

Millions of people have received COVID-19 vaccines under the most intense safety monitoring of any vaccine in U.S. history. Serious adverse events after vaccination are rare.